X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
n-acetylgalactosamine-6-sulfatase (24) 24
index medicus (13) 13
humans (11) 11
mucopolysaccharidosis (11) 11
enzymes (9) 9
galns gene (9) 9
genetics & heredity (9) 9
mucopolysaccharidosis iva (9) 9
morquio a syndrome (8) 8
mutation (8) 8
chondroitinsulfatases - genetics (7) 7
keratan sulfate (7) 7
man (7) 7
mucopolysaccharidosis type iva (7) 7
n-acetylgalactosamine (7) 7
analysis (6) 6
female (6) 6
galns (6) 6
mucopolysaccharidosis iv - genetics (6) 6
diagnosis (5) 5
disease (5) 5
enzyme replacement therapy (5) 5
lysosomal storage diseases (5) 5
medicine (5) 5
sulfates (5) 5
adolescent (4) 4
amino acid sequence (4) 4
chondroitinsulfatases - metabolism (4) 4
elosulfase alfa (4) 4
genetic aspects (4) 4
glycosaminoglycans (4) 4
identification (4) 4
male (4) 4
morquio's syndrome (4) 4
mucopolysaccharidosis iv - enzymology (4) 4
phenotype (4) 4
research (4) 4
biology (3) 3
child, preschool (3) 3
deficiency (3) 3
dna mutational analysis (3) 3
gene mutations (3) 3
genes (3) 3
human n-acetylgalactosamine-6-sulfate sulfatase (3) 3
lysosomal storage disorders (3) 3
mass spectrometry (3) 3
medical screening (3) 3
medicine, research & experimental (3) 3
metabolic disorders (3) 3
morquio (3) 3
morquio-disease (3) 3
mucopolysaccharidosis iv - pathology (3) 3
patients (3) 3
prognosis (3) 3
scientific imaging (3) 3
sense organs (3) 3
sulfate (3) 3
adult (2) 2
animals (2) 2
bio-plex immunoassay (2) 2
biochemistry (2) 2
biochemistry & molecular biology (2) 2
births (2) 2
bmn 110 (2) 2
bmn-110 (2) 2
child (2) 2
children (2) 2
chondroitin sulfate (2) 2
chondroitinsulfatases - chemistry (2) 2
elosulfase alpha (2) 2
enzymatic activity (2) 2
enzyme replacement therapy - methods (2) 2
enzyme-replacement therapy (2) 2
ert, enzyme replacement therapy (2) 2
fibroblasts (2) 2
galns, n-acetylgalactosamine-6-sulfatase (2) 2
genetic association studies (2) 2
genetic predisposition to disease (2) 2
genetic research (2) 2
genetics and genomics (2) 2
genotype (2) 2
genotype & phenotype (2) 2
haplotypes (2) 2
haplotypes - genetics (2) 2
immunoassay (2) 2
infant (2) 2
lysosomal storage disorder (2) 2
lysosomes (2) 2
management (2) 2
medical laboratory technology (2) 2
methods (2) 2
molecular sequence data (2) 2
morquio a (2) 2
morquio-a disease (2) 2
mps iva (2) 2
mucopolysaccharidosis iv - diagnosis (2) 2
mucopolysaccharidosis iv - drug therapy (2) 2
mutation - genetics (2) 2
mutations (2) 2
pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Chemistry, ISSN 0009-9147, 06/2017, Volume 63, Issue 6, pp. 1118 - 1126
Journal Article
by He, Xin and Xu, Jing and Xu, Jin
Chinese Journal of New Drugs, ISSN 1003-3734, 04/2015, Volume 24, Issue 8, pp. 841 - 856
Journal Article
ORPHANET JOURNAL OF RARE DISEASES, ISSN 1750-1172, 06/2019, Volume 14, Issue 1, pp. 137 - 25
Journal Article
Human Mutation, ISSN 1059-7794, 03/2015, Volume 36, Issue 3, pp. 357 - 368
Journal Article
Journal of Applied Genetics, ISSN 1234-1983, 2/2018, Volume 59, Issue 1, pp. 73 - 80
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 8, p. e12194
Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a lysosomal storage disorder caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), an... 
HUMAN N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE | MPS IVA | MURINE MODEL | BIOLOGY | MATRIX COMPONENTS | HUMAN ARTICULAR CHONDROCYTES | LYSOSOMAL STORAGE DISORDERS | MORQUIO-A DISEASE | KERATAN SULFATE | SKELETAL DEVELOPMENT | DEFICIENCY | Recombinant Proteins - therapeutic use | Liver - pathology | Humans | Chondroitinsulfatases - therapeutic use | Recombinant Proteins - pharmacokinetics | Heart Valves - metabolism | Recombinant Proteins - isolation & purification | Chondroitinsulfatases - isolation & purification | Chondroitinsulfatases - metabolism | Lysosomes - metabolism | Biological Transport | Cattle | Mucopolysaccharidosis IV - pathology | Female | Chondrocytes - metabolism | Recombinant Proteins - metabolism | Chondrocytes - pathology | Mucopolysaccharidosis IV - metabolism | Keratan Sulfate - metabolism | Cartilage - metabolism | Growth Plate - metabolism | Mucopolysaccharidosis IV - drug therapy | Chondroitinsulfatases - pharmacokinetics | Gene Expression Regulation - drug effects | Enzyme Replacement Therapy - methods | Macrophages - metabolism | Animals | Mice | Phosphates | Enzymes | Analysis | Collagen | Mucopolysaccharidosis | Models | Sulfates | Gene expression | Therapy | N-Acetylgalactosamine | Collagen (type I) | Intravenous administration | Enzyme activity | Disease | Collagen (type II) | Sox9 protein | Keratan sulfate | Liver | Medical services | Lysosomes | Homeostasis | Mannose | Arthritis | Hydroxyapatite | Macrophages | Bone surgery | Cartilage | Growth plate | Enzymatic activity | Collagen (type X) | Rodents | Animal tissues | Fibroblasts | Bone marrow | Recombinant | Mortality | Heart valves | Pathology | Storage | Hepatocytes | Chondrocytes | Sulfate | Aberration | Aggrecan | N-Acetylgalactosamine-6-sulfatase | Pharmaceuticals | Animal models
Journal Article
Molecular Genetics and Metabolism Reports, ISSN 2214-4269, 12/2017, Volume 13, Issue C, pp. 76 - 79
Enzyme replacement therapy (ERT) with elosulfase alfa is the only approved therapy in Japan for patients with Morquio A syndrome, a lysosomal storage disorder... 
Morquio A syndrome | Mucopolysaccharidosis type IV A | Non-ambulatory | Case report | Enzyme replacement therapy | Elosulfase alfa | EFFICACY | SAFETY | GENETICS & HEREDITY | BMN 110 | MUCOPOLYSACCHARIDOSIS IVA
Journal Article